Çocuklarda Human Papillomavirüs (HPV) Enfeksiyonları

Cason J, Mant CA. High-risk mucosal human papillomavirus infections during infancy & childhood. J Clin Virol. 2005;32 Suppl 1:52-58. doi: 10.1016/j.jcv.2004.12.007.
Müller M, Viscidi RP, Ulken V, et al. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. J Invest Dermatol. 1995;104(1):138-141. doi: 10.1111/1523-1747.ep12613659.
Syrjänen S, Waterboer T, Rintala M, et al. Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life. Sci Rep. 2022;12(1):2227. doi: 10.1038/s41598-022-06343-z.
Newall AT, Brotherton JM, Quinn HE, et al. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis. 2008;46(11):1647-1655. doi: 10.1086/587895.
Scherpenisse M, Mollers M, Schepp RM, et al. Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine. 2012;30(47):6686-6693. doi: 10.1016/j.vaccine.2012.08.068.
Sabeena S, Bhat P, Kamath V, et al. Possible non-sexual modes of transmission of human papilloma virus. J Obstet Gynaecol Res. 2017;43(3):429-435. doi: 10.1111/jog.13248.
Bunney MH, Barr BB, McLaren K, et al. Human papillomavirus type 5 and skin cancer in renal allograft recipients. Lancet. 1987;2(8551):151-152. doi: 10.1016/s0140-6736(87)92346-4.
Lee SM, Park JS, Norwitz ER, et al. Risk of vertical transmission of human papillomavirus throughout pregnancy: a prospective study. PLoS One. 2013;8(6):e66368. doi: 10.1371/journal.pone.0066368.
Freitas AC, Mariz FC, Silva MA, et al. Human papillomavirus vertical transmission: review of current data. Clin Infect Dis. 2013;56(10):1451-6. doi: 10.1093/cid/cit066..
Chatzistamatiou K, Sotiriadis A, Agorastos T. Effect of mode of delivery on vertical human papillomavirus transmission - A meta-analysis. J Obstet Gynaecol. 2016;36(1):10-14. doi: 10.3109/01443615.2015.1030606.
Medeiros LR, Ethur AB, Hilgert JB, et al. Vertical transmission of the human papillomavirus: a systematic quantitative review. Cad Saude Publica. 2005;21(4):1006-1015. doi: 10.1590/s0102-311x2005000400003.
Petca A, Borislavschi A, Zvanca ME, et al. Non-sexual HPV transmission and role of vaccination for a better future (Review). Exp Ther Med. 2020;20(6):186. doi: 10.3892/etm.2020.9316.
Awasthi S, Ornelas J, Armstrong A, et al. Anogenital warts and relationship to child sexual abuse: Systematic review and meta-analysis. Pediatr Dermatol. 2021;38(4):842-850. doi: 10.1111/pde.14650.
Bussen S, Sütterlin M, Schmidt U, et al. Anogenital Warts in Childhood - Always a Marker for Sexual Abuse? Geburtshilfe Frauenheilkd. 2012;72(1):43-48. doi: 10.1055/s-0031-1280417.
Mammas IN, Sourvinos G, Spandidos DA. Human papilloma virus (HPV) infection in children and adolescents. Eur J Pediatr. 2009;168(3):267-273. doi: 10.1007/s00431-008-0882-z.
Aguilera-Barrantes I, Magro C, Nuovo GJ. Verruca vulgaris of the vulva in children and adults: a nonvenereal type of vulvar wart. Am J Surg Pathol. 2007;31(4):529-535. doi: 10.1097/01.pas.0000213409.41182.56.
van Haalen FM, Bruggink SC, Gussekloo J, et al. Warts in primary schoolchildren: prevalence and relation with environmental factors. Br J Dermatol. 2009;161(1):148-152. doi: 10.1111/j.1365-2133.2009.09160.x.
Ren Z, Silverberg JI. Association of Atopic Dermatitis With Bacterial, Fungal, Viral, and Sexually Transmitted Skin Infections. Dermatitis. 2020;31(2):157-164. doi: 10.1097/DER.0000000000000526.
Howley PM, Pfister HJ. Beta genus papillomaviruses and skin cancer. Virology. 2015;479-480:290-296. doi: 10.1016/j.virol.2015.02.004.
Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol. 2012;130(5):1030-1048. doi: 10.1016/j.jaci.2012.07.049.
Bristow I. Paediatric Cutaneous Warts and Verrucae: An Update. Int J Environ Res Public Health. 2022;19(24):16400. doi: 10.3390/ijerph192416400.
Essa N, Saleh MA, Mostafa RM, et al. Prevalence and factors associated with warts in primary school children in Tema District, Sohag Governorate, Egypt. J Egypt Public Health Assoc. 2019;94(1):6. doi: 10.1186/s42506-018-0007-0.
Bruggink SC, Eekhof JA, Egberts PF, et al. Warts transmitted in families and schools: a prospective cohort. Pediatrics. 2013;131(5):928-934. doi: 10.1542/peds.2012-2946.
de Koning MN, Quint KD, Bruggink SC, et al. High prevalence of cutaneous warts in elementary school children and the ubiquitous presence of wart-associated human papillomavirus on clinically normal skin. Br J Dermatol. 2015;172(1):196-201. doi: 10.1111/bjd.13216.
de Planell-Mas E, Martínez-Garriga B, Zalacain AJ, et al. Human papillomaviruses genotyping in plantar warts. J Med Virol. 2017;89(5):902-907. doi: 10.1002/jmv.24713.
Tomson N, Sterling J, Ahmed I, et al. Human papillomavirus typing of warts and response to cryotherapy. J Eur Acad Dermatol Venereol. 2011;25(9):1108-1111. doi: 10.1111/j.1468-3083.2010.03906.x.
Bae JM, Kang H, Kim HO, Park YM. Differential diagnosis of plantar wart from corn, callus and healed wart with the aid of dermoscopy. Br J Dermatol. 2009;160(1):220-222. doi: 10.1111/j.1365-2133.2008.08937.x.
Hogendoorn GK, Bruggink SC, Hermans KE, et al. Developing and validating the Cutaneous WARTS (CWARTS) diagnostic tool: a novel clinical assessment and classification system for cutaneous warts. Br J Dermatol. 2018;178(2):527-534. doi: 10.1111/bjd.15999.
Hogendoorn GK, Bruggink SC, de Koning MNC, et al. Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous warts. Br J Dermatol. 2018;178(1):253-260. doi: 10.1111/bjd.15758.
Sterling JC, Gibbs S, Haque Hussain SS, et al. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712. doi: 10.1111/bjd.13310.
Williams HC, Pottier A, Strachan D. The descriptive epidemiology of warts in British school children. J. Br. Podiatr. Med. 1994;49:171-176. doi: 10.1111/j.1365-2133.1993.tb00226.x
Bruggink SC, Gussekloo J, de Koning MN, et al. HPV type in plantar warts influences natural course and treatment response: secondary analysis of a randomised controlled trial. J Clin Virol. 2013;57(3):227-232. doi: 10.1016/j.jcv.2013.02.021.
Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol. 2002;19(3):263-266. doi: 10.1046/j.1525-1470.2002.00083.x.
Soenjoyo KR, Chua BWB, Wee LWY, et al. Treatment of cutaneous viral warts in children: A review. Dermatol Ther. 2020;33(6):e14034. doi: 10.1111/dth.14034.
Daniel BS, Murrell DF. Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine. JAMA Dermatol. 2013;149(3):370-372. doi: 10.1001/jamadermatol.2013.1463.
Kreuter A, Waterboer T, Wieland U. Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination. Arch Dermatol. 2010;146(10):1196-7. doi: 10.1001/archdermatol.2010.290.
Abeck D, Fölster-Holst R. Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children. Acta Derm Venereol. 2015;95(8):1017-1019. doi: 10.2340/00015555-2111.
Betz SJ. HPV-Related Papillary Lesions of the Oral Mucosa: A Review. Head Neck Pathol. 2019;13(1):80-90. doi: 10.1007/s12105-019-01003-7.
Piña AR, Fonseca FP, Pontes FS, et al. Benign epithelial oral lesions - association with human papillomavirus. Med Oral Patol Oral Cir Bucal. 2019;24(3):290-295. doi: 10.4317/medoral.22817.
R JA, C N, Aishwarya N. A case report of squamous papilloma of the hard palate in a pediatric patient. J Indian Soc Pedod Prev Dent. 2020;38(1):91-93. doi: 10.4103/JISPPD.JISPPD_71_18.
Gillison ML, Chaturvedi AK, Anderson WF, et al. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015;33(29):3235-3242. doi: 10.1200/JCO.2015.61.6995.
Di Spirito F, Pantaleo G, Di Palo MP, et al. Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review. Cancers (Basel). 2023;15(4):1096. doi: 10.3390/cancers15041096.
Naik S, Nidoni M. Oral squamous papilloma of the palate-A case report. Int J Dent Sci Res. 2014;6:17-18. doi: 10.12691/ijdsr-2-6B-5.
Castro TP, Bussoloti Filho I. Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol. 2006;72(2):272-282. doi: 10.1016/s1808-8694(15)30068-9.
Sinal SH, Woods CR. Human papillomavirus infections of the genital and respiratory tracts in young children. Semin Pediatr Infect Dis. 2005;16(4):306-316. doi: 10.1053/j.spid.2005.06.010.
Seedat RY. Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review. Pediatric Health Med Ther. 2020;11:39-46. doi: 10.2147/PHMT.S200186.
Betiol J, Villa LL, Sichero L. Impact of HPV infection on the development of head and neck cancer. Braz J Med Biol Res. 2013;46(3):217-226. doi: 10.1590/1414-431x20132703.
Ivancic R, Iqbal H, deSilva B, et al. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018;3(1):22-34. doi: 10.1002/lio2.132.
Sinclair KA, Woods CR, Sinal SH. Venereal warts in children. Pediatr Rev. 2011;32(3):115-121; quiz 121. doi: 10.1542/pir.32-3-115.
Stefanaki C, Barkas G, Valari M, Bethimoutis G, Nicolaidou E, Vosynioti V, Kontochristopoulos G, Papadogeorgaki H, Verra P, Katsarou A. Condylomata acuminata in children. Pediatr Infect Dis J. 2012;31(4):422-424. doi: 10.1097/INF.0b013e318245a589.
Unger ER, Fajman NN, Maloney EM, et al. Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study. Pediatrics. 2011;128(3):e658-65. doi: 10.1542/peds.2010-2247.
Sinclair KA, Woods CR, Kirse DJ, et al. Anogenital and respiratory tract human papillomavirus infections among children: age, gender, and potential transmission through sexual abuse. Pediatrics. 2005;116(4):815-825. doi: 10.1542/peds.2005-0652.
Syrjänen S. Current concepts on human papillomavirus infections in children. APMIS. 2010;118(6-7):494-509. doi: 10.1111/j.1600-0463.2010.02620.x.
Jayasinghe Y, Garland SM. Genital warts in children: what do they mean? Arch Dis Child. 2006;91(8):696-700. doi: 10.1136/adc.2005.092080.
Allen AL, Siegfried EC. The natural history of condyloma in children. J Am Acad Dermatol. 1998;39(6):951-955. doi: 10.1016/s0190-9622(98)70268-3.
Herzum A, Ciccarese G, Occella C, et al. Treatment of Pediatric Anogenital Warts in the Era of HPV-Vaccine: A Literature Review. J Clin Med. 2023;12(13):4230. doi: 10.3390/jcm12134230.
Tuncel A, Görgü M, Ayhan M, et al. Treatment of anogenital warts by pulsed dye laser. Dermatol Surg. 2002;28(4):350-352. doi: 10.1046/j.1524-4725.2002.01172.x. PMID: 11966796.
Theotoka D, Morkin MI, Galor A, et al. Update on Diagnosis and Management of Conjunctival Papilloma. Eye Vis (Lond). 2019;6:18. doi: 10.1186/s40662-019-0142-5.
Ardekani A, Taherifard E, Mollalo A, et al. Human Papillomavirus Infection during Pregnancy and Childhood: A Comprehensive Review. Microorganisms. 2022;10(10):1932. doi: 10.3390/microorganisms10101932.
Sjö NC, von Buchwald C, Cassonnet P, et al. Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. Br J Ophthalmol. 2007;91(8):1014-1015. doi: 10.1136/bjo.2006.108811.
D Kalogeropoulos C, M Moschos M. Advances in Diagnosis and Treatment of HPV Ocular Surface Infections. Med Hypothesis Discov Innov Ophthalmol. 2015;4(2):31-35. PMID: 26060827; PMCID: PMC4458323.
Chalkia AK, Spandidos DA, Detorakis ET. Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review). Int J Mol Med. 2013;32(3):539-543. doi: 10.3892/ijmm.2013.1438.
Murthy N, Wodi AP, McNally VV, et al. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(1):11-15. doi: 10.15585/mmwr.mm7301a3.
Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1-30.
Saslow D, Andrews KS, Manassaram-Baptiste D, et al; American Cancer Society Guideline Development Group. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. CA Cancer J Clin. 2020;70(4):274-280. doi: 10.3322/caac.21616.
Human Papillomavirus vaccines: World Health Organization position paper, December 2022. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/position-papers/human-papillomavirus-(hpv) (Accessed on February 10, 2024).
Garland SM, Hernandez-Avila M, Wheeler CM, et al; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928-1943. doi: 10.1056/NEJMoa061760.
Van Damme P, Olsson SE, Block S, et al. Immunogenicity and Safety of a 9-Valent HPV Vaccine. Pediatrics. 2015;136(1):28-39. doi: 10.1542/peds.2014-3745.
Sow PS, Watson-Jones D, Kiviat N, et al. Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women. J Infect Dis. 2013;207(11):1753-1763. doi: 10.1093/infdis/jis619.
Kjaer SK, Nygård M, Dillner J, et al. A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clin Infect Dis. 2018;66(3):339-345. doi: 10.1093/cid/cix797.
Restrepo J, Herrera T, Samakoses R, et al. Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety. Pediatrics. 2023;152(4):e2022060993. doi: 10.1542/peds.2022-060993.
Adjei Boakye E, Nair M, Abouelella DK, et al. Trends in Reasons for Human Papillomavirus Vaccine Hesitancy: 2010-2020. Pediatrics. 2023;151(6):e2022060410. doi: 10.1542/peds.2022-060410.
Lu PJ, Yankey D, Fredua B, et al. Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States. J Pediatr. 2019;206:33-41.e1. doi: 10.1016/j.jpeds.2018.10.034.
Niccolai LM, Hansen CE. Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review. JAMA Pediatr. 2015;169(7):686-692. doi: 10.1001/jamapediatrics.2015.0310.
Newman PA, Logie CH, Lacombe-Duncan A, et al. Parents' uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8(4):e019206. doi: 10.1136/bmjopen-2017-019206.
Batista Ferrer H, Trotter CL, Hickman M, et al. Barriers and facilitators to uptake of the school-based HPV vaccination programme in an ethnically diverse group of young women. J Public Health (Oxf). 2016;38(3):569-577. doi: 10.1093/pubmed/fdv073.
Güneş Ö, Özkaya-Parlakay A, Güney AY, et al. A Survey on Parents' Health Literacy on Childhood Human Papilloma Virus Vaccination. J Pediatr Infect Dis. 2023;18(01):046-054. doi: 10.1055/s-0042-1760374
Wei F, Alberts CJ, Albuquerque A, et al. Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis. J Infect Dis. 2023;228(11):1496-1504. doi: 10.1093/infdis/jiad183. PMID: 37257044.
Herrero R, Quint W, Hildesheim A, et al; CVT Vaccine Group. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7):e68329. doi: 10.1371/journal.pone.0068329.
Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011 Feb 3;364(5):401-411. doi: 10.1056/NEJMoa0909537.
Novakovic D, Cheng ATL, Zurynski Y, et al. A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program. J Infect Dis. 2018;217(2):208-212. doi: 10.1093/infdis/jix498.